Arrow Clinical Trials · Daytona Beach, FL

ALZHEIMER'S RESEARCH STUDY · VOLUSIA, FLAGLER, BREVARD & SEMINOLE

When Alzheimer's brings hallucinations, fear, or paranoia.

Caring for someone with Alzheimer's who is seeing things, becoming fearful, or growing suspicious can be frightening and isolating. There is a research study here in Daytona Beach for people living with these symptoms, and as the person who knows them best, you would take part by their side as their study partner.

Speak with our local study team. No pressure, no obligation, and learning if you qualify doesn't commit you to anything.

Does this sound like someone you love?

  • Seeing people or things that aren't there, such as someone standing in the room or by the bed

  • Hearing voices or sounds that no one else can hear

  • Becoming fearful or suspicious, or thinking strangers are in the house

  • Accusing family of stealing, or believing a loved one is an impostor or a stranger

  • Sudden fear, agitation, or distress that is hard to explain

If you're caring for someone with Alzheimer's and any of this feels familiar, you're not imagining it, and you're not alone. These experiences are more common than people realize. They come from the changes Alzheimer's causes in the brain, and doctors sometimes call them Alzheimer's psychosis.

What families are asking

What is Alzheimer's psychosis?
It refers to hallucinations (seeing or hearing things that aren't there) and delusions (strongly held false beliefs, like paranoia or believing a loved one is an impostor) in a person with Alzheimer's disease. It's one of the most distressing symptoms for families, and more common than most people realize.
Is there a treatment for it?
There is currently no FDA-approved medication specifically for psychosis in Alzheimer's disease. Doctors often turn to medications approved for other conditions, which can carry significant side effects. Clinical research studies are how potential new options are evaluated.
What is this study?
Our research site in Daytona Beach is conducting a clinical research study evaluating an investigational study medication for hallucinations and delusions associated with Alzheimer's disease. "Investigational" means it is still being studied and is not approved by the FDA. The study is conducted under a study physician and overseen by an independent review board.
Who can take part?
Adults diagnosed with Alzheimer's disease who are experiencing hallucinations or delusions. Each participant takes part alongside a study partner, usually a family member or caregiver who knows them well and can attend study visits. That study partner may be you.
What if my loved one can't make decisions for themselves?
That's common with Alzheimer's, and the study is built for it. Where a person can't provide informed consent themselves, a legally authorized representative can give permission on their behalf, along with the participant's agreement. Our team walks you through exactly how it works.
Is it safe?
The study medication is investigational, so its safety and effectiveness are still being studied and are not yet established. Participants are monitored closely throughout by a study physician, and the study is reviewed by an independent ethics board whose role is to protect participants. The team explains all potential risks before you decide anything.

We make taking part as easy as possible

  • Door-to-door transportation. Available on request, so there's no driving or parking to worry about.

  • Flexible appointment times. Scheduled around your day, with one local contact who handles the details.

  • No cost, no insurance needed. Study visits, lab tests, brain imaging, and the study medication are all provided at no cost to you.

  • Compensation for your time. Provided for each completed visit, for both the participant and the study partner.

  • Layered medical oversight. Close monitoring by your local study physician, backed by a research study conducted with physicians and safety experts at centers around the world.

  • A local team that knows you. Care close to home in Daytona Beach, from people you'll recognize each visit.

Be part of something bigger

By taking part, you and your loved one may help researchers better understand Alzheimer's psychosis and move closer to options that could help other families, here and around the world, in the years ahead.

Find out if your loved one may qualify

A short, no-pressure phone call is all it takes.

OR, HAVE US CALL YOU

Our study doctors

David Billmeier, MD

PRINCIPAL INVESTIGATOR

Board-certified in Family Medicine and in Hospice and Palliative Medicine, David Billmeier, MD has cared for the greater Daytona community for more than 25 years and has worked in clinical research for the past decade, with particular expertise in central nervous system and neurodegenerative conditions, including Alzheimer's disease.


Charles Ross, MD

INVESTIGATOR

Board-certified in Family Medicine and a Fellow of the American Academy of Family Physicians, Charles Ross, MD has practiced since 2006 and serves as clinical faculty training physicians at the University of South Florida and Nova Southeastern University. His research interests include Alzheimer's and Parkinson's disease.

This research is conducted at Arrow Clinical Trials, a community-based research site at 1717 N. Clyde Morris Blvd., Suite 120, Daytona Beach, FL 32117, serving families across Volusia and Flagler counties. The study is overseen by an independent institutional review board (IRB).

Learn more about our site at arrowclinicaltrials.com.

This is a clinical research study. Participation is voluntary, and you may stop at any time for any reason.

© Arrow Clinical Trials · Daytona Beach, FL · arrowclinicaltrials.com